Suppr超能文献

相似文献

1
Clinical effect of point mutations in myelodysplastic syndromes.
N Engl J Med. 2011 Jun 30;364(26):2496-506. doi: 10.1056/NEJMoa1013343.
2
Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience.
Medicine (Baltimore). 2024 Oct 11;103(41):e39909. doi: 10.1097/MD.0000000000039909.
3
Myelodysplastic syndromes: Contemporary review and how we treat.
Am J Hematol. 2016 Jan;91(1):76-89. doi: 10.1002/ajh.24253.
4
Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome.
Mol Biol Rep. 2024 Sep 15;51(1):985. doi: 10.1007/s11033-024-09922-7.
5
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
J Clin Oncol. 2011 Jun 20;29(18):2499-506. doi: 10.1200/JCO.2010.33.4938. Epub 2011 May 16.
6
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
J Clin Oncol. 2012 Sep 20;30(27):3376-82. doi: 10.1200/JCO.2011.40.7379. Epub 2012 Aug 6.
8
The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
Genes (Basel). 2021 Jul 27;12(8):1144. doi: 10.3390/genes12081144.

引用本文的文献

4
Humanized mouse models in MDS.
Cell Death Dis. 2025 Jul 17;16(1):531. doi: 10.1038/s41419-025-07861-0.
5
Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with mutant MDS/AML.
Hemasphere. 2025 Jul 13;9(7):e70164. doi: 10.1002/hem3.70164. eCollection 2025 Jul.
6
Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective.
Genes (Basel). 2025 Jun 2;16(6):687. doi: 10.3390/genes16060687.
7
Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects.
Biomolecules. 2025 May 25;15(6):761. doi: 10.3390/biom15060761.

本文引用的文献

1
Unraveling the molecular pathophysiology of myelodysplastic syndromes.
J Clin Oncol. 2011 Feb 10;29(5):504-15. doi: 10.1200/JCO.2010.31.1175. Epub 2011 Jan 10.
2
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Nature. 2010 Dec 9;468(7325):839-43. doi: 10.1038/nature09586.
5
Diverse somatic mutation patterns and pathway alterations in human cancers.
Nature. 2010 Aug 12;466(7308):869-73. doi: 10.1038/nature09208. Epub 2010 Jul 28.
6
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Nat Genet. 2010 Aug;42(8):722-6. doi: 10.1038/ng.621. Epub 2010 Jul 4.
7
Recurrent BRAF mutations in Langerhans cell histiocytosis.
Blood. 2010 Sep 16;116(11):1919-23. doi: 10.1182/blood-2010-04-279083. Epub 2010 Jun 2.
8
Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).
Leukemia. 2010 Jul;24(7):1370-2. doi: 10.1038/leu.2010.98. Epub 2010 May 20.
10
The epidemiology of myelodysplastic syndromes.
Hematol Oncol Clin North Am. 2010 Apr;24(2):287-94. doi: 10.1016/j.hoc.2010.02.011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验